Crossmark

Bevacizumab decreases vestibular schwannomas growth rate in children and teenagers with neurofibromatosis type 2

Crossref DOI link: https://doi.org/10.1007/s11060-015-1828-8

Published Online: 2015-05-29

Published Print: 2015-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hochart, Audrey

Gaillard, Vianney

Baroncini, Marc

André, Nicolas

Vannier, Jean-Pierre

Vinchon, Matthieu

Dubrulle, Frederique

Lejeune, Jean-Paul

Vincent, Christophe

Nève, Véronique

Sudour Bonnange, Héléne

Bonne, Nicolas Xavier

Leblond, Pierre
License Information

Text and Data Mining valid from 2015-05-29